128 related articles for article (PubMed ID: 8142011)
1. Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
Rumsby PC; Davies MJ; Evans JG
Mol Carcinog; 1994 Feb; 9(2):71-5. PubMed ID: 8142011
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
Rumsby PC; Barrass NC; Phillimore HE; Evans JG
Carcinogenesis; 1991 Dec; 12(12):2331-6. PubMed ID: 1747936
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors.
Kress S; König J; Schweizer J; Löhrke H; Bauer-Hofmann R; Schwarz M
Mol Carcinog; 1992; 6(2):148-58. PubMed ID: 1382443
[TBL] [Abstract][Full Text] [Related]
5. Growth characteristics and Ha-ras mutations of cell cultures isolated from chemically induced mouse liver tumours.
Pedrick MS; Rumsby PC; Wright V; Phillimore HE; Butler WH; Evans JG
Carcinogenesis; 1994 Sep; 15(9):1847-52. PubMed ID: 7522981
[TBL] [Abstract][Full Text] [Related]
6. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
7. ras oncogene mutations in diethylnitrosamine-induced hepatic tumors in medaka (Oryzias latipes), a teleost fish.
Liu Z; Kullman SW; Bencic DC; Torten M; Hinton DE
Mutat Res; 2003 Aug; 539(1-2):43-53. PubMed ID: 12948813
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
Naito M; Satake M; Sakai E; Hirano Y; Tsuchida N; Kanzaki H; Ito Y; Mori T
Jpn J Cancer Res; 1992 Oct; 83(10):1030-6. PubMed ID: 1333465
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
10. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
Buchmann A; Bauer-Hofmann R; Mahr J; Drinkwater NR; Luz A; Schwarz M
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):911-5. PubMed ID: 1992483
[TBL] [Abstract][Full Text] [Related]
11. B-raf and Ha-ras mutations in chemically induced mouse liver tumors.
Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M
Oncogene; 2005 Feb; 24(7):1290-5. PubMed ID: 15592514
[TBL] [Abstract][Full Text] [Related]
12. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
Wang Y; Wang Y; Stoner G; You M
Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
[TBL] [Abstract][Full Text] [Related]
13. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
14. Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H/He mice.
Bauer-Hofmann R; Klimek F; Buchmann A; Müller O; Bannasch P; Schwarz M
Mol Carcinog; 1992; 6(1):60-7. PubMed ID: 1323970
[TBL] [Abstract][Full Text] [Related]
15. Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens.
Tokusashi Y; Fukuda I; Ogawa K
Mol Carcinog; 1994 May; 10(1):45-51. PubMed ID: 8185829
[TBL] [Abstract][Full Text] [Related]
16. Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors.
Goodrow TL; Storer RD; Leander KR; Prahalada SR; van Zwieten MJ; Bradley MO
Mol Carcinog; 1992; 5(1):9-15. PubMed ID: 1543544
[TBL] [Abstract][Full Text] [Related]
17. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.
Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ
Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770
[TBL] [Abstract][Full Text] [Related]
19. Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats.
Stowers SJ; Wiseman RW; Ward JM; Miller EC; Miller JA; Anderson MW; Eva A
Carcinogenesis; 1988 Feb; 9(2):271-6. PubMed ID: 2827904
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
